Heart Failure Reviews

Papers
(The H4-Index of Heart Failure Reviews is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Heart failure and COVID-19139
Biomarkers for the diagnosis and management of heart failure128
COVID-19 and myocarditis: a systematic review and overview of current challenges115
Machine learning versus conventional clinical methods in guiding management of heart failure patients—a systematic review54
Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment53
Mechanisms of COVID-19-induced heart failure: a short review44
Extracellular matrix–based biomaterials for cardiac regeneration and repair44
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments41
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets40
Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers40
Polypharmacy definition and prevalence in heart failure: a systematic review40
SGLT2-inhibitors; more than just glycosuria and diuresis39
The prognostic role of speckle tracking echocardiography in clinical practice: evidence and reference values from the literature38
Clinical inertia in the treatment of heart failure: a major issue to tackle38
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications36
Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia: a systematic review and meta-analysis35
The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis34
Non-ischemic dilated cardiomyopathy and cardiac fibrosis34
Therapeutic angiogenesis with exosomal microRNAs: an effectual approach for the treatment of myocardial ischemia33
The Elabela-APJ axis: a promising therapeutic target for heart failure33
The role and molecular mechanism of epigenetics in cardiac hypertrophy30
The role of non-invasive devices for the telemonitoring of heart failure patients29
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness27
Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress26
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges25
Resistance training in heart failure patients: a systematic review and meta-analysis25
0.033885955810547